Emerging therapies for glioblastoma: current state and future directions

Glioblastoma (GBM) is the most common high-grade primary malignant brain tumor with an extremely poor prognosis. Given the poor survival with currently approved treatments for GBM, new therapeutic strategies are urgently needed. Advances in decades of investment in basic science of glioblastoma are...

Descripción completa

Detalles Bibliográficos
Autores principales: Rong, Liang, Li, Ni, Zhang, Zhenzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013078/
https://www.ncbi.nlm.nih.gov/pubmed/35428347
http://dx.doi.org/10.1186/s13046-022-02349-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013078/
https://www.ncbi.nlm.nih.gov/pubmed/35428347
http://dx.doi.org/10.1186/s13046-022-02349-7

Ejemplares similares